Lipid droplets may lay a spacial foundation for vasculogenic mimicry formation in hepatocellular carcinoma

Medical Hypotheses

Volumn 83, Issue 1, 2014, Pages 56-59

  Li, Yue ^a   Cai, Weiwei ^a   Yi, Qingqing ^a   Xie, Fengshan ^a   Liu, Yanling ^a   Du, Bin ^a   Feng, Lei ^a   Qiu, Liying ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET;

ANGIOGENESIS; ARTICLE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MORPHOLOGICAL TRAIT; ONCOGENESIS AND MALIGNANT TRANSFORMATION; STEATOSIS; TUMOR MICROENVIRONMENT; VASCULOGENIC MIMICRY; BLOOD VESSEL; LIPID METABOLISM; LIVER TUMOR; METABOLISM; VASCULARIZATION;

BLOOD VESSELS; CARCINOMA, HEPATOCELLULAR; HUMANS; LIPID METABOLISM; LIVER NEOPLASMS;

EID: 84901038701     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.04.009     Document Type: Article

References (44)

1. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002, 29(6 Suppl. 16):15-18.
2. Maniotis A.J., Folberg R., Hess A., et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999, 155(3):739-752.
3. Guzman G., Cotler S.J., Lin A.Y., Maniotis A.J., Folberg R. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch Pathol Lab Med 2007, 131(12):1776-1781.
4. Liu X.M., Zhang Q.P., Mu Y.G., et al. Clinical significance of vasculogenic mimicry in human gliomas. J Neurooncol 2011, 105(2):173-179.
5. Sood A.K., Fletcher M.S., Zahn C.M., et al. The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy. Cancer Biol Ther 2002, 1(6):661-664.
6. Yue W.Y., Chen Z.P. Does vasculogenic mimicry exist in astrocytoma?. J Histochem Cytochem 2005, 53(8):997-1002.
7. Liu R., Yang K., Meng C., Zhang Z., Xu Y. Vasculogenic mimicry is a marker of poor prognosis in prostate cancer. Cancer Biol Ther 2012, 13(7):527-533.
8. Sun B., Zhang S., Zhang D., et al. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep 2006, 16(4):693-698.
9. Cao Z., Bao M., Miele L., Sarkar F.H., Wang Z., Zhou Q. Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. Eur J Cancer 2013, 49(18):3914-3923.
10. Hendrix M.J., Seftor E.A., Hess A.R., Seftor R.E. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 2003, 3(6):411-421.
11. Vartanian A.A. Signaling pathways in tumor vasculogenic mimicry. Biochemistry (Mosc) 2012, 77(9):1044-1055.
12. Zhang S., Zhang D., Sun B. Vasculogenic mimicry: current status and future prospects. Cancer Lett 2007, 254(2):157-164.
13. Franceschi S., Raza S.A. Epidemiology and prevention of hepatocellular carcinoma. Cancer Lett 2009, 286(1):5-8.
14. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63(1):11-30.
15. Salomao M., McMillen E., Lefkowitch J.H. Recent advances in the classification of hepatocellular carcinoma. Diagn Histopathol 2012, 18(1):37-45.
16. Kutami R., Nakashima Y., Nakashima O., Shiota K., Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 2000, 33(2):282-289.
17. Wei W. The pathomorphology study of early hepatocellular carcinoma: steatosis. Foreign Med Sci 1990, 17(08):371-372.
18. Kukla M., Gabriel A., Wilk M., Liszka L., Petelenz M., Frelich I. Steatosis induces angiogenesis in chronic hepatitis C. J Hepatol 2009, 50(Suppl. 1):S151.
19. Kukla M., Gabriel A., Sabat D., et al. Association between liver steatosis and angiogenesis in chronic hepatitis C. Pol J Pathol 2010, 61(3):154-160.
20. Bozza P.T., Viola J.P. Lipid droplets in inflammation and cancer. Prostaglandins Leukot Essent Fatty Acids 2010, 82(4-6):243-250.
21. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407(6801):249-257.
22. Plate K.H., Scholz A., Dumont D.J. Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited. Acta Neuropathol 2012, 124(6):763-775.
23. Seftor R.E., Hess A.R., Seftor E.A., et al. Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am J Pathol 2012, 181(4):1115-1125.
24. Döme B., Hendrix M.J., Paku S., Tóvári J., Tímár J. Alternative vascularization mechanisms in cancer: pathology and therapeutic implications. Am J Pathol 2007, 170(1):1-15.
25. Zhang S., Li M., Zhang D., et al. Hypoxia influences linearly patterned programmed cell necrosis and tumor blood supply patterns formation in melanoma. Lab Invest 2009, 89(5):575-586.
26. Han C., Sun B.U., Wang W., et al. A pilot study on morphology and the mechanism involved in linearly patterned programmed cell necrosis in melanoma. Oncol Lett 2010, 1(5):821-826.
27. Liu Z., Li Y., Zhao W., Ma Y., Yang X. Demonstration of vasculogenic mimicry in astrocytomas and effects of Endostar on U251 cells. Pathol Res Pract 2011, 207(10):645-651.
28. Sun B., Qie S., Zhang S., et al. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol 2008, 39(3):444-451.
29. Wang J.Y., Sun T., Zhao X.L., et al. Functional significance of VEGF-a in human ovarian carcinoma. Cancer Biol Ther 2008, 7(5):758-766.
30. Zhang S., Zhang D., Wang Y., et al. Morphologic research of microcirculation patterns in human and animal melanoma. Med Oncol 2006, 23(3):403-409.
31. Opstad K.S., Bell B.A., Griffiths J.R., Howe F.A. An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRS and histological analysis. NMR Biomed 2008, 21(7):677-685.
32. Accioly M.T., Pacheco P., Maya-Monteiro C.M., et al. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res 2008, 68(6):1732-1740.
33. Zadra G., Photopoulos C., Loda M. The fat side of prostate cancer. Biochim Biophys Acta 2013, 1831(10):1518-1532.
34. Than N.G., Sumegi B., Bellyei S., et al. Lipid droplet and milk lipid globule membrane associated placental protein 17b (PP17b) is involved in apoptotic and differentiation processes of human epithelial cervical carcinoma cells. Eur J Biochem 2003, 270(6):1176-1188.
35. Swinnen J.V., Brusselmans K., Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006, 9(4):358-365.
36. Kuhajda F.P. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 2006, 66(12):5977-5980.
37. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012, 21(3):297-308.
38. Carracedo A., Cantley L.C. Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 2013, 13(4):227-232.
39. Currie E., Schulze A., Zechner R., Walther T.C., Farese R.V. Cellular fatty acid metabolism and cancer. Cell Metab 2013, 18(2):153-161.
40. Sonveaux P., Végran F., Schroeder T., et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008, 118(12):3930-3942.
41. Cao Y., Arbiser J., D'Amato R.J., et al. Forty-year journey of angiogenesis translational research. Sci Transl Med 2011, 3(114):114rv3.
42. Pàez-Ribes M., Allen E., Hudock J., et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009, 15(3):220-231.
43. Carbone C., Moccia T., Zhu C., et al. Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. Clin Cancer Res 2011, 17(17):5822-5832.
44. Qu B., Guo L., Ma J., Lv Y. Antiangiogenesis therapy might have the unintended effect of promoting tumor metastasis by increasing an alternative circulatory system. Med Hypotheses 2010, 74(2):360-361.